DexCom DPO Ratio 2011-2026 | DXCM

Annual DPO Ratio DexCom

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
67.7	71.1	70.4	76	83.8	75	68.6	74.9	75.3	45.9	56.1	43.6	25.6	26.7	25.3

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
83.8	25.3	59.1

Quarterly DPO Ratio DexCom

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
88.1	79.3	-	72.2	69.7	69.4	-	66.4	75.2	82.5	-	32.8	27.8	67.1	-	84.4	81.5	89.3	-	92.8	88.9	81.5	-	62.5	71.9	72.6	-	70.2	77.5	85.1	-	-	-	-	-	-	-	-	-	56.8	63.7	50.1	-	41.4	47.8	37.2	-	25.1	27.6	28.2	-	24.2	44.4	61.1	-	25.4	13.4	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
92.8	13.4	60.4

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
Biomerica BMRA	32.4	$ 2.13	-2.74 %	$ 4.89 M	USA
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
Castle Biosciences CSTL	52	$ 25.75	3.0 %	$ 715 M	USA
Quest Diagnostics Incorporated DGX	14.7	$ 195.6	0.17 %	$ 21.7 B	USA
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	112	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	106	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	49.2	$ 104.91	-	$ 19.8 B	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	34.9	$ 16.33	5.29 %	$ 494 M	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
Charles River Laboratories International CRL	24.5	$ 158.0	2.86 %	$ 7.83 B	USA
IQVIA Holdings IQV	126	$ 166.96	0.54 %	$ 28.7 B	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
Invitae Corporation NVTA	69	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	149	$ 1.46	26.96 %	$ 1.86 M	USA
Interpace Biosciences IDXG	34.4	$ 1.71	0.73 %	$ 7.5 M	USA
IDEXX Laboratories IDXX	24.9	$ 578.51	0.22 %	$ 46.5 B	USA
Agilent Technologies A	50.1	$ 112.02	0.65 %	$ 34.1 B	USA
Illumina ILMN	56.3	$ 123.79	-0.43 %	$ 19.7 B	USA
ICON Public Limited Company ICLR	6.52	$ 100.35	0.65 %	$ 8.28 B	Irlanda
DarioHealth Corp. DRIO	112	$ 7.5	-6.13 %	$ 29.9 M	Israel
Guardant Health GH	48.6	$ 84.9	-0.33 %	$ 10.6 B	USA
QIAGEN N.V. QGEN	50	-	-	$ 10.6 B	Niderland
CareDx, Inc CDNA	44.2	$ 17.56	2.39 %	$ 936 M	USA
Lantheus Holdings LNTH	23.6	$ 75.73	-0.92 %	$ 5.11 B	USA
Medpace Holdings MEDP	13.3	$ 456.93	0.98 %	$ 13.2 B	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	31.5	$ 264.42	0.54 %	$ 22 B	USA
Motus GI Holdings MOTS	1.72	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	53.4	$ 1 239.07	2.87 %	$ 25.5 B	Schweiz
Myriad Genetics MYGN	45.9	$ 4.66	1.75 %	$ 432 M	USA
ENDRA Life Sciences NDRA	1.65 K	$ 3.48	0.87 %	$ 1.87 M	USA
NeoGenomics NEO	19.7	$ 8.1	1.76 %	$ 1.04 B	USA
National Research Corporation NRC	10.1	$ 17.51	1.1 %	$ 392 M	USA
Natera NTRA	17.9	$ 200.09	2.46 %	$ 19.7 B	USA
OPKO Health OPK	43.1	$ 1.15	2.68 %	$ 798 M	USA
Pacific Biosciences of California PACB	59.7	$ 1.39	4.51 %	$ 417 M	USA
RadNet RDNT	23.5	$ 61.74	0.41 %	$ 4.64 B	USA
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA